Evidence map›Paper›PMID 38381906›Full record

ArticleNucleic acids research2024

Pathogenic CANVAS (AAGGG)n repeats stall DNA replication due to the formation of alternative DNA structures.

Julia A Hisey, Elina A Radchenko, Nicholas H Mandel, Ryan J McGinty, Gabriel Matos-Rodrigues, Anastasia Rastokina, Chiara Masnovo, Silvia Ceschi, Alfredo Hernandez, André Nussenzweig and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Dynamic Assemblies in Genome Maintenance.Advances in experimental medicine and biology · 2026
    Review
  3. Review
  4. Article
  5. Review
  6. Emerging drivers of DNA repeat expansions.Biochemical Society transactions · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Neurology. Genetics · 2024
    Article
  11. Article
  12. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Julia A HiseyDepartment of Biology, Tufts University, Medford, MA 02155, USA.
Elina A RadchenkoDepartment of Biology, Tufts University, Medford, MA 02155, USA.
Nicholas H MandelDepartment of Biology, Tufts University, Medford, MA 02155, USA.
Ryan J McGintyDepartment of Biomedical Informatics, Harvard Medical School, Boston, MA02115, USA.
Gabriel Matos-RodriguesLaboratory of Genome Integrity, National Cancer Institute NIH, Bethesda, MD20892, USA.
Anastasia RastokinaDepartment of Biology, Tufts University, Medford, MA 02155, USA.
Chiara MasnovoDepartment of Biology, Tufts University, Medford, MA 02155, USA.ORCID 0000-0003-3414-6369
Silvia CeschiDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova 35131, Italy.
Alfredo HernandezDepartment of Biology, Tufts University, Medford, MA 02155, USA.
André NussenzweigLaboratory of Genome Integrity, National Cancer Institute NIH, Bethesda, MD20892, USA.
Sergei M MirkinDepartment of Biology, Tufts University, Medford, MA 02155, USA.ORCID 0000-0003-4576-7582
Tufts University · USNational Cancer Institute · USHarvard University · USUniversity of Padua · IT

Funding

DNA RepairZIABC010283 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI NUSSENZWEIG, ANDRE A. · 2009 to 2025
$27.0M
Relationship between DNA damage detection and signalingZIABC010959 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI NUSSENZWEIG, ANDRE A. · 2009 to 2025
$27.0M
The origin, the function and the phenotypic impact of human allelesR35GM127131 · NIGMS · HARVARD MEDICAL SCHOOL · PI SHAMIL SUNYAEV · 2018 to 2026
$8.1M
NIGMS Equipment SupplementR35GM130322 · NIGMS · TUFTS UNIVERSITY MEDFORD · PI SERGEI MIRKIN · 2019 to 2026
$4.6M
Medical Scientist Training Program at Tufts UniversityT32GM146621 · NIGMS · TUFTS UNIVERSITY BOSTON · PI MICHAEL T CHIN · 2023 to 2026
$2.1M
NCI NIH HHS HHSN261201000031CNCI NIH HHS HHSN261201500001CNCI NIH HHS HHSN2612015000031NCI NIH HHS HHSN261201500003CNCI NIH HHS HHSN261201500003INIGMS NIH HHS R35 GM127131NIGMS NIH HHS R35GM127131NIGMS NIH HHS R35 GM130322NIGMS NIH HHS R35GM130322NIGMS NIH HHS T32 GM146621
6 · The paper itself

Abstract

CANVAS is a recently characterized repeat expansion disease, most commonly caused by homozygous expansions of an intronic (A2G3)n repeat in the RFC1 gene. There are a multitude of repeat motifs found in the human population at this locus, some of which are pathogenic and others benign. In this study, we conducted structure-functional analyses of the pathogenic (A2G3)n and nonpathogenic (A4G)n repeats. We found that the pathogenic, but not the nonpathogenic, repeat presents a potent, orientation-dependent impediment to DNA polymerization in vitro. The pattern of the polymerization blockage is consistent with triplex or quadruplex formation in the presence of magnesium or potassium ions, respectively. Chemical probing of both repeats in vitro reveals triplex H-DNA formation by only the pathogenic repeat. Consistently, bioinformatic analysis of S1-END-seq data from human cell lines shows preferential H-DNA formation genome-wide by (A2G3)n motifs over (A4G)n motifs. Finally, the pathogenic, but not the nonpathogenic, repeat stalls replication fork progression in yeast and human cells. We hypothesize that the CANVAS-causing (A2G3)n repeat represents a challenge to genome stability by folding into alternative DNA structures that stall DNA replication.

Indexed as

Cerebellar AtaxiaDNA Repeat ExpansionDNA ReplicationPeripheral Nervous System DiseasesVestibular DiseasesDNAHumansNucleic Acid ConformationReplication Protein CCANVAS syndromeDNAReplication Protein CRFC1 protein, humantriplex DNA

Identifiers

PMID38381906
PMCPMC11077069
OpenAlexW4391992795

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.